CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report)’s share price fell 3.2% during trading on Thursday . The company traded as low as $1.40 and last traded at $1.41. 73,320 shares were traded during trading, a decline of 93% from the average session volume of 982,370 shares. The stock had previously closed at $1.46.
CERo Therapeutics Price Performance
The company’s 50-day moving average is $2.39.
About CERo Therapeutics
CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Further Reading
- Five stocks we like better than CERo Therapeutics
- The Role Economic Reports Play in a Successful Investment Strategy
- Hasbro’s Management Made All the Right Calls This Quarter
- Why is the Ex-Dividend Date Significant to Investors?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- High Flyers: 3 Natural Gas Stocks for March 2022
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
